EUVIMEDAtrasti EUVIMED
Video/Audio

Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients

Qiong Liu, Nan Ding, Zhijuan Hu

Journal of Visualized Experiments · 2026

DOI: 10.3791/70901 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Qiong Liu and 2 co-authors. Institution: Department of Nephrology, Hebei General Hospital; lq800813@163.com. Major MEDLINE topics: Probucol, Diabetic Nephropathies, Vitamin D.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

This study aimed to investigate the therapeutic efficacy of vitamin D as an adjunct to probucol-based triple therapy (valsartan + atorvastatin + probucol) in patients with diabetic nephropathy (DN) and to evaluate its impact on immune function. A total of 150 DN patients (Mogensen stage III) were retrospectively enrolled from July 2022 to May 2024. Based on the different medication regimens received in clinical practice, they were divided into a control group (n = 56) receiving triple therapy (valsartan + atorvastatin + probucol) and an observation group (n = 94) receiving quadruple therapy (triple therapy + vitamin D). Group assignment was determined by the actual treatment administered, not by randomization. Both groups received daily insulin infusions concurrently for 8 months. Clinical parameters, including renal function (SCr, 24 h UPE, UAlb/UCR), glucose and lipid profiles, immune markers (CD3+, CD4+ cells, CD4+/CD8+ ratio), and inflammatory factors (hs-CRP, IL-6, TNF-α, MCP-1), were assessed pre- and post-treatment. Results demonstrated that the observation group showed significantly greater improvements in renal function, glycemic control, lipid profiles, and immune modulation (elevated proportions of CD3+ and CD4+, a higher CD4+/CD8+ ratio, and reduced inflammatory markers) compared with the control group (all P

Subjects

MeSH terms (MEDLINE)

ProbucolDiabetic NephropathiesVitamin DHumansFemaleMaleMiddle AgedDrug Therapy, CombinationValsartanAtorvastatinRetrospective StudiesAgedAnticholesteremic Agents

Substances

ProbucolVitamin DValsartanAtorvastatinAnticholesteremic Agents

Authors and institutions

  • Department of Nephrology, Hebei General Hospital; lq800813@163.com.
  • Department of Clinical Laboratory, Hebei General Hospital.
  • Department of Nephrology, Hebei General Hospital.

Cite

APA

Liu, Q., Ding, N., & Hu, Z. (2026). Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients. Journal of Visualized Experiments. https://doi.org/10.3791/70901

Vancouver

Liu Q, Ding N, Hu Z. Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients. Journal of Visualized Experiments. 2026. doi:10.3791/70901

BibTeX
@article{Liu2026,
  author = {Liu, Qiong and Ding, Nan and Hu, Zhijuan},
  title = {Clinical Observation of Adding Vitamin D to a Probucol-Based Regimen in Diabetic Nephropathy Patients},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70901}
}
Start for free →